Susquehanna Advisors Group »

Dexcom shares owned by Susquehanna Advisors Group

Quarter-by-quarter ownership of Dexcom shares owned by Susquehanna Advisors Group from 13F filings

Historical chart of Susquehanna Advisors Group investment in Dexcom

Tip: Access up to 7 years of quarterly data

All positions including Dexcom held by Susquehanna Advisors Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dexcom by Susquehanna Advisors Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $182k 18M 0.01

More positions owned by Susquehanna Advisors Group

Applovin Corp Com Cl A Call Option (APP)
Costco Wholesale Corporation (COST)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Meta Platforms Cl A (META)
Strategy Note 2.250% 6/1 (Principal)
Jd.com Spon Ads Cl A (JD)
Eli Lilly & Co. (LLY)
Alnylam Pharmaceuticals (ALNY)
Pfizer (PFE)
Pdd Holdings Sponsored Ads (PDD)
Strategy Cl A New Put Option (MSTR)
salesforce (CRM)
Broadcom (AVGO)
Asml Holding N V N Y Registry Shs (ASML)

View all positions for Susquehanna Advisors Group

Top funds holding Dexcom

Hudson Bay Capital Management
Tenor Capital Management
Radcliffe Capital Management
DeepCurrents Investment Group
Capstone Investment Advisors
Lazard Asset Management
Millennium Management
Osterweis Capital Management
Franklin Resources
Toronto-Dominion Bank
State Street Corporation
Kohlberg Kravis Roberts & Co
Glazer Capital
Susquehanna Advisors Group
Commonwealth of Pennsylvania

View all funds holding Dexcom